OXT and lung carcinoma: Nonetheless, our data shows that a co‐expressed pattern of the SOX2‐OT/SOX2/GLI‐1 ‘trinomial axis’ is likely involved in therapy failure and poorer clinical prognosis, through epigenetic mechanisms which interact in lung cancer drug resistance.